The European Specialist Medical Qualifications Amendment Regulations 2002
Citation and commencement1.
These Regulations may be cited as the European Specialist Medical Qualifications Amendment Regulations 2002 and shall come into force on 17th April 2002.
Amendment of the European Specialist Medical Qualifications Order 19952.
(1)
(2)
In paragraph (4) of article 7 after the word “published” insert “following approval by the STA”.
(3)
“(4A)
In order to satisfy the STA that a doctor has particular expertise in a field such that he is entitled to have that expertise indicated in the register under paragraph (4)(b), the doctor must satisfy the STA that he has satisfactorily completed—
(a)
an STA approved sub-speciality training scheme in the United Kingdom; or
(b)
any other sub-speciality training scheme outside the United Kingdom that the STA is satisfied is equivalent to an STA approved sub-speciality training scheme.”.
(4)
In Part II of Schedule 2, in the appropriate alphabetical position, insert “Pharmaceutical medicine”.
These Regulations amend the European Specialist Medical Qualifications Order 1995 (“the 1995 Order”), which implemented European obligations contained principally in Council Directive 93/16/EEC (OJ No. L165, 7.7.93, p. 1) relating to the training of specialist doctors and mutual recognition of their qualifications.
Article 7(4) of the 1995 Order is amended to provide that the curriculum and any other requirements relating to the training for each speciality must be approved by the Specialist Training Authority (“STA”) prior to publication.
Article 8 is amended to provide that for sub-speciality recognition on the specialist register, a doctor must either satisfy the STA that he has satisfactorily completed an STA approved sub-speciality training scheme in the UK or that he has satisfactorily completed any other sub-speciality training scheme outside the UK, which the STA is satisfied is equivalent to an STA approved sub-speciality training scheme.
Part II of Schedule 2 to the 1995 Order is amended by adding a new speciality (pharmaceutical medicine) to the list of “Other Specialities”.